Pharmacy managers inflated drug prices by $7.3 billion

The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...
The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...